Some drug patents in the Biden administration's crosshairs
The White House says it can use "march-in rights" to seize patents for certain medicines partly developed with federal funds. Host Katherine Ellen Foley talks with POLITICO White House Correspondent Adam Cancryn about how the move could give the president another tool in his effort to lower drug prices. Learn more about your ad choices. Visit megaphone.fm/adchoices